Navigation Links
Solos Endoscopy, Inc. Receives Purchase Order from Cleveland Clinic
Date:1/6/2009

BOSTON, Jan. 6 /PRNewswire/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has received a significant purchase order for the Mammo View(TM) line of surgical endoscopy instruments from the Cleveland Clinic in Cleveland, OH. The Cleveland Clinic currently operates nine community hospitals and three affiliate hospitals which are accredited by the Joint Commission on Accreditation of Healthcare Organization (JCAHO).

Cleveland Clinic, located in Cleveland, Ohio, is a not-for-profit, multispecialty academic medical center that integrates clinical and hospital care with research and education. Founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation, Cleveland Clinic has become one of the largest and most respected hospitals in the country. Cleveland Clinic facilities can be found throughout Northeast Ohio, as well as, around the country and world

"We are pleased to have the Cleveland Clinic as a client of Solos Endoscopy. We believe the purchase order from a client of this caliber once again validates our surgical products as some of the best on the market. As the Company looks toward the New Year, we will continue to grow our client base and implement strategies to maximize our shareholders value," stated Bob Segersten, President of Solos Endoscopy, Inc.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at: www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.


'/>"/>
SOURCE Solos Endoscopy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Solos Endoscopy, Inc. Increases Sales Revenue for October 2008 by Over 10% as Compared to Last Year
2. Solos Endoscopy, Inc.s Mammo View(TM) System Now Used in Womens Hospital of Baton Rouge, LA
3. Solos Endoscopy, Inc. Posts First Six Months Financials of 2008 on Pinksheets.com
4. Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia
5. Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum
6. Scantek Medical Files for Chapter 11 Voluntary Bankruptcy and Receives Orders for the Sale of BreastCare(TM)
7. Immtech Receives Listing Notice From NYSE Alternext US
8. Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance
9. EMC Receives Express Scripts IT Supplier of the Year Award
10. Mylans Matrix Receives Final FDA Approval for the Generic Version of the Antiretroviral Zerit(R) Capsules
11. Watson Pharmaceuticals Receives FDA Final Approval for Generic Mircette(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... PA (PRWEB) , ... November 30, 2016 , ... "I ... hand and arm while brushing my teeth," said an inventor from Bridgewater, N.J. "I ... me to develop this handy device." , He developed the patent-pending DEFLECTOR to prevent ...
(Date:11/30/2016)... Gardens, FL (PRWEB) , ... November 30, 2016 ... ... eating disorder and mental health treatment has announced the opening of a new ... specialized partial hospitalization and intensive outpatient treatment for adults and adolescents, both males ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... have been a focus of public policymakers and system stakeholders in many states. ... released its Medical Price Index for Workers’ Compensation, Eighth Edition (MPI-WC) . ...
(Date:11/30/2016)... Austin, TX (PRWEB) , ... November 30, 2016 ... ... like to remind the clinical research community that the FDA Binding Guidance goes ... submit data in FDA-supported formats listed in the FDA Data Standards Catalog. The ...
(Date:11/30/2016)... ... 2016 , ... U.S. Security Associates (USA) announced the acquisition ... Richmond, Virginia. The acquisition further strengthens USA’s capabilities within the expanding healthcare ... prides itself on 100% client-retention to the healthcare industry. In addition, ODS has ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2, 2016 Quantum Radiology,s Mobile Breast Center ... interpretation directly to women at the workplace, thereby maximizing ... as Delta Air Lines and SunTrust Bank, and community ... component of wellness initiatives. "I think it,s ... enables them to have a mammogram without taking a ...
(Date:12/2/2016)... Dec. 2, 2016  The Addiction Treatment Advisory ... of Managed Care Pharmacy (AMCP), has released detailed ... address the opioid addiction crisis, including through improved ... ATAG,s newly released paper, "The Role ... Naloxone," addresses many issues around gaps and barriers ...
(Date:12/2/2016)... R.I. , Dec. 2, 2016 CVS ... its annual Analyst Day in New York City on Thursday, December 15, ... CVS Health leadership team will provide an in-depth review ... enhance shareholder value. The company will also discuss 2017 ... and video webcast of the event will be broadcast ...
Breaking Medicine Technology: